Therapy of hypereosinophilic syndrome
Selected Abstract
Therapy of hypereosinophilic syndrome, polycythemia vera, atypical CML or CMML with PDGF-R fusion genes, or mastocytosis with Gleevec.(CLINICAL TRIAL REVIEW)
This study is currently recruiting patients. Sponsored by M.D. Anderson Cancer Center. The goal of this clinical research study is to see if Gleevec[R], known as imatinib mesylate (ST1571), can improve the disease condition in patients with hypereosinophilic syndrome, polycythemia vera, atypical ... March 1, 2005; Journal of Drugs in Dermatology
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Therapy of hypereosinophilic syndrome, polycythemia vera, atypical CML or CMML with PDGF-R fusion genes, or mastocytosis with Gleevec.(CLINICAL TRIAL REVIEW)
|
